NASDAQ: ADRX
Adarx Pharmaceuticals Inc Stock Ownership - Who owns Adarx Pharmaceuticals?

Insider buying vs selling

Have Adarx Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Erez ChimovitsDirector2026-09-2861,516$17.00
$1.05MBuy
Simeon GeorgeDirector2026-09-28592,593$17.00
$10.07MBuy
Simeon GeorgeDirector2026-09-28414,814$17.00
$7.05MBuy
Simeon GeorgeDirector2026-09-28592,593$17.00
$10.07MBuy
Carl L. GordonDirector2026-09-28300,249$17.00
$5.10MBuy
Carl L. GordonDirector2026-09-2861,516$17.00
$1.05MBuy
Carl L. GordonDirector2026-09-28588,235$17.00
$10.00MBuy
Orbimed Advisors LLCDirector2026-09-28300,249$17.00
$5.10MBuy
Orbimed Advisors LLCDirector2026-09-2861,516$17.00
$1.05MBuy
Orbimed Advisors LLCDirector2026-09-28588,235$17.00
$10.00MBuy

1 of 2

ADRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADRX insiders and whales buy or sell their stock.

ADRX Shareholders

What type of owners hold Adarx Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lav Biosciences Fund V LP11.60%11,858,655$157.72MInsider
Sr One Capital Management LLC9.72%9,936,661$132.16MInsider
Simeon George9.72%9,936,661$132.16MInsider
Erez Chimovits9.09%9,292,025$123.58MInsider
Zhen 1. Li5.73%5,861,199$77.95MInsider
Rui Nmn Zhu2.46%2,511,943$33.41MInsider
Orbimed Advisors LLC0.58%588,235$7.82MInsider
Carl L. Gordon0.58%588,235$7.82MInsider

1 of 1

ADRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRV0.05%36.80%Net BuyingNet Selling
ABVX0.07%0.00%
ADMA0.09%25.59%Net SellingNet Selling
ADXN0.00%17.47%
ABUS0.05%99.95%Net SellingNet Selling

Adarx Pharmaceuticals Stock Ownership FAQ

Who owns Adarx Pharmaceuticals?

Adarx Pharmaceuticals (NASDAQ: ADRX) is owned by 0.00% institutional shareholders, 49.48% Adarx Pharmaceuticals insiders, and 50.52% retail investors. Lav Biosciences Fund V LP is the largest individual Adarx Pharmaceuticals shareholder, owning 11.86M shares representing 11.60% of the company. Lav Biosciences Fund V LP's Adarx Pharmaceuticals shares are currently valued at $176.81M.

If you're new to stock investing, here's how to buy Adarx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.